ON DEMAND: Mycoplasma Testing: An Automated Alternative to Traditional NAT Methods
The standard test for mycoplasma contamination is evolving. As macromolecule drugs derived from mammalian cells become more commonplace, reducing the turnaround time for testing has become essential for manufacturers to ensure productivity. The pressure to reduce the turnaround time has spurred innovation with real-time PCR methods. The vision for future testing is simple to use, fast, and accurate.
Learn more about how Amgen continues to boost their productivity by adopting the Next Generation Nucleic Acid Amplification Test with Chakameh Azimpour, AMGEN Principal Scientist and our own Jeremy Robertson, bioMérieux Global Solution Manager for the BIOFIRE® Mycoplasma.